{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 456517, "items": [{"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T15:55:18Z", "timestamp": 1574438118942}, "reference-count": 117, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1901, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1755-5949.2010.00175.x", "type": "journal-article", "created": {"date-parts": [[2010, 6, 18]], "date-time": "2010-06-18T10:47:43Z", "timestamp": 1276858063000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?"], "prefix": "10.1111", "author": [{"given": "Alessandro", "family": "Martorana", "sequence": "first", "affiliation": []}, {"given": "Zaira", "family": "Esposito", "sequence": "additional", "affiliation": []}, {"given": "Giacomo", "family": "Koch", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 6, 18]]}, "reference": [{"key": "10.1111/j.1755-5949.2010.00175.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1126/science.1072994", "article-title": "The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics", "volume": "297", "author": "Hardy", "year": "2002", "journal-title": "Science"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1126/science.7046051", "article-title": "The cholinergic hypothesis of geriatric memory dysfunction", "volume": "217", "author": "Bartus", "year": "1982", "journal-title": "Science"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1016/j.neuropharm.2007.07.013", "article-title": "Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse", "volume": "53", "author": "Parsons", "year": "2007", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1007/s12017-009-8091-0", "article-title": "Alzheimer's disease amyloid beta-protein and synaptic function", "volume": "12", "author": "Ondrejcak", "year": "2010", "journal-title": "Neuromolecular Med"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.4088/PCC.v05n0602", "article-title": "Long-term cholinesterase inhibitor therapy for Alzheimer's disease: Practical considerations for the primary care physician", "volume": "5", "author": "Geldmacher", "year": "2003", "journal-title": "Prim Care Companion J Clin Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB6|cit6", "first-page": "417", "article-title": "Realistic expectations for treatment success in Alzheimer's disease", "volume": "10", "author": "Geldmacher", "year": "2006", "journal-title": "J Nutr Health Aging"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1097/00019442-200407000-00003", "article-title": "Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease", "volume": "12", "author": "Ritchie", "year": "2004", "journal-title": "Am J Geriatr Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.4088/PCC.v07n0403", "article-title": "Treating patients with moderate to severe Alzheimer's disease: Implications of recent pharmacologic studies", "volume": "7", "author": "Forchetti", "year": "2005", "journal-title": "Prim Care Companion J Clin Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB9|cit9", "author": "Birks", "first-page": "CD005593", "year": "2006", "article-title": "Cholinesterase inhibitors for Alzheimer's disease", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3310/hta10010", "article-title": "The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease", "volume": "10", "author": "Loveman", "year": "2006", "journal-title": "Health Technol Assess"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.4088/PCC.v08n0306", "article-title": "A systematic review of assessment and treatment of moderate to severe Alzheimer's disease", "volume": "8", "author": "Schmitt", "year": "2006", "journal-title": "Prim Care Companion J Clin Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1002/gps.1402", "article-title": "A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease", "volume": "21", "author": "Takeda", "year": "2006", "journal-title": "Int J Geriatr Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.7326/0003-4819-148-5-200803040-00009", "article-title": "Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline", "volume": "148", "author": "Raina", "year": "2008", "journal-title": "Ann Intern Med"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.2165/00002512-200724020-00007", "article-title": "Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis", "volume": "24", "author": "Hansen", "year": "2007", "journal-title": "Drugs Aging"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB15|cit15", "first-page": "211", "article-title": "Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis", "volume": "3", "author": "Hansen", "year": "2008", "journal-title": "Clin Interv Aging"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1186/alzrt7", "article-title": "Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease", "volume": "1", "author": "Rountree", "year": "2009", "journal-title": "Alzheimers Res Ther"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.2174/1874205X00903010027", "article-title": "Pharmacological treatment of Alzheimer's disease: Is it progressing adequately?", "volume": "3", "author": "Robles", "year": "2009", "journal-title": "Open Neurol J"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB18|cit18", "author": "Birks", "first-page": "CD001190", "year": "2000", "article-title": "Donepezil for mild and moderate Alzheimer's disease", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "828", "DOI": "10.1002/jnr.490410613", "article-title": "Second generation cholinesterase inhibitors: Effect of (L)-huperzine-A on cortical biogenic amines", "volume": "41", "author": "Zhu", "year": "1995", "journal-title": "J Neurosci Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "268", "DOI": "10.1016/S0006-8993(00)02266-6", "article-title": "In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus", "volume": "865", "author": "Trabace", "year": "2000", "journal-title": "Brain Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/0028-3908(95)00157-3", "article-title": "The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex", "volume": "35", "author": "Giacobini", "year": "1996", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1016/j.tips.2004.12.010", "article-title": "A preclinical view of cholinesterase inhibitors in neuroprotection: Do they provide more than symptomatic benefits in Alzheimer's disease?", "volume": "26", "author": "Francis", "year": "2005", "journal-title": "Trends Pharmacol Sci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.2174/156720509787602861", "article-title": "Cholinesterase inhibitors and beyond", "volume": "6", "author": "Pepeu", "year": "2009", "journal-title": "Curr Alzheimer Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.2165/00023210-200721030-00001", "article-title": "The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer's disease", "volume": "21", "author": "Iliffe", "year": "2007", "journal-title": "CNS Drugs"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1016/S0531-5565(00)00206-0", "article-title": "Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons", "volume": "36", "author": "Schredl", "year": "2001", "journal-title": "Exp Gerontol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1016/j.biopsych.2006.08.034", "article-title": "The relationship between REM sleep and memory consolidation in old age and effects of cholinergic medication.", "volume": "61", "author": "Hornung", "year": "2007", "journal-title": "Biol Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1016/0165-0173(95)00016-X", "article-title": "Acetylcholine: A neurotransmitter for learning and memory?", "volume": "21", "author": "Blokland", "year": "1995", "journal-title": "Brain Res Brain Res Rev"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "7797", "DOI": "10.1523/JNEUROSCI.1885-08.2008", "article-title": "Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory", "volume": "28", "author": "Wisman", "year": "2008", "journal-title": "J Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1111/j.1471-4159.2006.04262.x", "article-title": "Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: A parallel neurochemical and behavioural analysis", "volume": "100", "author": "Millan", "year": "2007", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1007/s00508-006-0737-4", "article-title": "Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model", "volume": "118", "author": "Brooks", "year": "2006", "journal-title": "Wien Klin Wochenschr"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/0006-8993(95)01092-0", "article-title": "Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin", "volume": "704", "author": "Cassel", "year": "1995", "journal-title": "Brain Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1111/j.1476-5381.1996.tb15232.x", "article-title": "Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release", "volume": "117", "author": "Clarke", "year": "1996", "journal-title": "Br J Pharmacol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1046/j.1471-4159.2000.0752409.x", "article-title": "Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release", "volume": "75", "author": "Kenny", "year": "2000", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "1071", "DOI": "10.1046/j.0022-3042.2002.00805.x", "article-title": "Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals", "volume": "80", "author": "Marchi", "year": "2002", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1007/s00213-003-1552-5", "article-title": "Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790", "volume": "170", "author": "Woolley", "year": "2003", "journal-title": "Psychopharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1124/mol.105.018184", "article-title": "Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: Interaction with glutamate and GABA systems and effect of nicotine withdrawal", "volume": "69", "author": "Barik", "year": "2006", "journal-title": "Mol Pharmacol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/j.neuropharm.2005.01.030", "article-title": "Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro", "volume": "49", "author": "Rousseau", "year": "2005", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1001/archneurol.2009.46", "article-title": "Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease", "volume": "66", "author": "Ikonomovic", "year": "2009", "journal-title": "Arch Neurol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/j.mehy.2009.09.011", "article-title": "Alpha7 neuronal nicotinic receptors: The missing link to understanding Alzheimer's etiopathology?", "volume": "74", "author": "Bencherif", "year": "2010", "journal-title": "Med Hypotheses"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "1771", "DOI": "10.1001/archneur.64.12.1771", "article-title": "Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease", "volume": "64", "author": "Counts", "year": "2007", "journal-title": "Arch Neurol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1002/syn.20526", "article-title": "Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholin receptors", "volume": "62", "author": "Galindo-Charles", "year": "2008", "journal-title": "Synapse"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "1015", "DOI": "10.1016/j.neuropharm.2008.06.061", "article-title": "An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function", "volume": "55", "author": "Fone", "year": "2008", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1016/j.neuropsychologia.2004.06.007", "article-title": "Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease", "volume": "43", "author": "Garcia-Alloza", "year": "2005", "journal-title": "Neuropsychologia"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1093/brain/awn326", "article-title": "Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease", "volume": "132", "author": "Smith", "year": "2009", "journal-title": "Brain"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1007/s00702-008-0082-z", "article-title": "L-dopa modulates motor cortex excitability in Alzheimer's disease patients", "volume": "115", "author": "Martorana", "year": "2008", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "2323", "DOI": "10.1038/npp.2009.60", "article-title": "Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients", "volume": "34", "author": "Martorana", "year": "2009", "journal-title": "Neuropsychopharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1038/sj.npp.1301485", "article-title": "Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens", "volume": "33", "author": "Preda", "year": "2008", "journal-title": "Neuropsychopharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.3233/JAD-2003-5602", "article-title": "Effects of donepezil treatment on rat nicotinic acetylcholine receptor levels in vivo and in vitro", "volume": "5", "author": "Reid", "year": "2003", "journal-title": "J Alzheimers Dis"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "1437", "DOI": "10.1007/s00702-008-0107-7", "article-title": "Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro?", "volume": "115", "author": "Reid", "year": "2008", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1007/s12035-008-8037-9", "article-title": "Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine", "volume": "38", "author": "Kenney", "year": "2008", "journal-title": "Mol Neurobiol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "752", "DOI": "10.1038/aps.2009.39", "article-title": "Nicotinic mechanisms influencing synaptic plasticity in the hippocampus", "volume": "30", "author": "Placzek", "year": "2009", "journal-title": "Acta Pharmacol Sin"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1124/mol.104.000299", "article-title": "Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release", "volume": "66", "author": "Zhang", "year": "2004", "journal-title": "Mol Pharmacol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "1116", "DOI": "10.1124/jpet.103.063586", "article-title": "Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats", "volume": "309", "author": "Sharp", "year": "2004", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1016/j.brainresbull.2005.12.001", "article-title": "Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study", "volume": "69", "author": "Shearman", "year": "2006", "journal-title": "Brain Res Bull"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1038/sj.npp.1301087", "article-title": "Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors", "volume": "32", "author": "Schilstr\u00f6m", "year": "2007", "journal-title": "Neuropsychopharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1002/cne.20684", "article-title": "Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: A potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release", "volume": "492", "author": "Berlanga", "year": "2005", "journal-title": "J Comp Neurol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1016/j.brainres.2006.10.049", "article-title": "Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain", "volume": "1131", "author": "Kumar", "year": "2007", "journal-title": "Brain Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "1795", "DOI": "10.1073/pnas.0400237101", "article-title": "Slow-wave sleep, acetylcholine, and memory consolidation", "volume": "101", "author": "Power", "year": "2004", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1101/lm.80504", "article-title": "Declarative memory consolidation: Mechanisms acting during human sleep", "volume": "11", "author": "Gais", "year": "2004", "journal-title": "Learn Member"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1162/jocn.2006.18.5.793", "article-title": "Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation", "volume": "18", "author": "Rasch", "year": "2006", "journal-title": "J Cogn Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1523/JNEUROSCI.0232-03.2004", "article-title": "Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area", "volume": "24", "author": "Saint-Mleux", "year": "2004", "journal-title": "J Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1523/JNEUROSCI.22-01-00029.2002", "article-title": "Synaptic potentials mediated by alpha 7 nicotinic acetylcholine receptors in supraoptic nucleus", "volume": "22", "author": "Hatton", "year": "2002", "journal-title": "J Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1016/S0165-0173(03)00143-7", "article-title": "The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes", "volume": "42", "author": "Berridge", "year": "2003", "journal-title": "Brain Res Brain Res Rev"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.brainresrev.2007.10.013", "article-title": "Noradrenergic modulation of arousal", "volume": "58", "author": "Berridge", "year": "2008", "journal-title": "Brain Res Rev"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1007/s11920-009-0004-2", "article-title": "Current treatments for sleep disturbances in individuals with dementia", "volume": "11", "author": "Deschennes", "year": "2009", "journal-title": "Curr Psychiatry Rep"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1097/00005072-199901000-00004", "article-title": "Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia", "volume": "58", "author": "Stopa", "year": "1999", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.2174/156720508784533286", "article-title": "Functional consequences of locus coeruleus degeneration in Alzheimer's disease", "volume": "5", "author": "Weinshenker", "year": "2008", "journal-title": "Curr Alzheimer Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1093/sleep/29.2.199", "article-title": "The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: A double-blind placebo-controlled study", "volume": "29", "author": "Moraes Wdos", "year": "2006", "journal-title": "Sleep"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.2165/00002512-200623060-00005", "article-title": "Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease", "volume": "23", "author": "Cooke", "year": "2006", "journal-title": "Drugs Aging"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "660", "DOI": "10.1111/j.1440-1819.2004.01317.x", "article-title": "Effects of donepezil on Alzheimer's disease: The relationship between cognitive function and rapid eye movement sleep", "volume": "58", "author": "Mizuno", "year": "2004", "journal-title": "Psychiatry Clin Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1159/000017126", "article-title": "The effects of donepezil in Alzheimer's disease - Results from a multinational trial", "volume": "10", "author": "Burns", "year": "1999", "journal-title": "Dement Geriatr Cogn Disord"}, {"issue": "Suppl 3", "key": "10.1111/j.1755-5949.2010.00175.x-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1159/000051201", "article-title": "Perspectives in the management of Alzheimer's disease: Clinical profile of donepezil", "volume": "9", "author": "Rogers", "year": "1998", "journal-title": "Dement Geriatr Cogn Disord"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1159/000090630", "article-title": "Circadian cholinergic rhythms: Implications for cholinesterase inhibitor therapy", "volume": "21", "author": "Davis", "year": "2006", "journal-title": "Dement Geriatr Cogn Disord"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1111/j.1742-1241.2009.02330.x", "article-title": "Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease", "volume": "64", "author": "Grossberg", "year": "2010", "journal-title": "Int J Clin Pract"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "3357", "DOI": "10.1185/03007990802522397", "article-title": "Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: Focus on galantamine", "volume": "24", "author": "Nieoullon", "year": "2008", "journal-title": "Curr Med Res Opin"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1023/A:1022869222652", "article-title": "Cholinesterases: New roles in brain function and in Alzheimer's disease", "volume": "28", "author": "Giacobini", "year": "2003", "journal-title": "Neurochem Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1016/S0006-3223(00)01100-8", "article-title": "Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity", "volume": "49", "author": "Shimohama", "year": "2001", "journal-title": "Biol Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1016/S0006-3223(00)01111-2", "article-title": "Nicotine and amyloid formation", "volume": "49", "author": "Zeng", "year": "2001", "journal-title": "Biol Psychiatry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "13568", "DOI": "10.1021/bi9617264", "article-title": "Nicotine inhibits amyloid formation by the beta-peptide", "volume": "35", "author": "Salomon", "year": "1996", "journal-title": "Biochemistry"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "2703", "DOI": "10.1111/j.0953-816X.2004.03377.x", "article-title": "Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice", "volume": "19", "author": "Hellstr\u00f6m-Lindahl", "year": "2004", "journal-title": "Eur J Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1046/j.1471-4159.2002.00874.x", "article-title": "Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)", "volume": "81", "author": "Nordberg", "year": "2002", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1016/j.neuropharm.2006.04.007", "article-title": "Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade", "volume": "51", "author": "Takada-Takatori", "year": "2006", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1248/bpb.32.318", "article-title": "Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation", "volume": "32", "author": "Takada-Takatori", "year": "2009", "journal-title": "Biol Pharm Bull"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "4125", "DOI": "10.1523/JNEUROSCI.21-12-04125.2001", "article-title": "Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease", "volume": "21", "author": "Dineley", "year": "2001", "journal-title": "J Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "22768", "DOI": "10.1074/jbc.M200164200", "article-title": "Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins", "volume": "277", "author": "Dineley", "year": "2002", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1016/j.brainres.2004.07.016", "article-title": "The alpha7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against beta-amyloid1-42 toxicity in primary neuron-enriched cultures", "volume": "1022", "author": "Martin", "year": "2004", "journal-title": "Brain Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/j.neuint.2008.12.001", "article-title": "Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro", "volume": "54", "author": "Mousavi", "year": "2009", "journal-title": "Neurochem Int"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1113/jphysiol.2007.149492", "article-title": "Aromatic residues at position 55 of rat alpha7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization", "volume": "586", "author": "Gay", "year": "2008", "journal-title": "J Physiol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "1979", "DOI": "10.1091/mbc.e06-12-1080", "article-title": "5-Hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling", "volume": "18", "author": "Barthet", "year": "2007", "journal-title": "Mol Biol Cell"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "1464", "DOI": "10.1038/sj.npp.1301512", "article-title": "MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors", "volume": "33", "author": "Mlinar", "year": "2008", "journal-title": "Neuropsychopharmacology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB91|cit91", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/j.bbr.2007.11.027", "article-title": "Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role", "volume": "195", "author": "Perez-Garcia", "year": "2008", "journal-title": "Behav Brain Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB92|cit92", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.2174/1567205043332252", "article-title": "New insights into serotonin 5-HT4 receptors: A novel therapeutic target for Alzheimer's disease?", "volume": "1", "author": "Maillet", "year": "2004", "journal-title": "Curr Alzheimer Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB93|cit93", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1016/j.expneurol.2006.07.021", "article-title": "Activation of 5-HT4 receptors inhibits secretion of beta-amyloid Peptides and increases neuronal survival", "volume": "203", "author": "Cho", "year": "2007", "journal-title": "Exp Neurol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "883", "DOI": "10.1038/sj.bjp.0707178", "article-title": "5-HT4 receptor agonists increase sAPP alpha levels in the cortex and hippocampus of male C57BL/6j mice", "volume": "150", "author": "Cachard-Chastel", "year": "2007", "journal-title": "Br J Pharmacol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "4482", "DOI": "10.1021/jm070552t", "article-title": "Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers", "volume": "50", "author": "Russo", "year": "2007", "journal-title": "J Med Chem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB96|cit96", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1016/j.bbr.2007.10.008", "article-title": "Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice", "volume": "187", "author": "Cachard-Chastel", "year": "2008", "journal-title": "Behav Brain Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB97|cit97", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0304-3940(93)90103-R", "article-title": "Coupling of muscarinic receptors to GTP proteins in postmortem human brain - Alterations in Alzheimer's disease", "volume": "150", "author": "Warpman", "year": "1993", "journal-title": "Neurosci Lett"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1002/jnr.490310115", "article-title": "Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia", "volume": "31", "author": "Nordberg", "year": "1992", "journal-title": "J Neurosci Res"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB99|cit99", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1016/S0024-3205(97)00038-6", "article-title": "Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain", "volume": "60", "author": "M\u00fcller", "year": "1997", "journal-title": "Life Sci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1006/bbrc.1998.8235", "article-title": "Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells", "volume": "244", "author": "DeLapp", "year": "1998", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB101|cit101", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1016/j.neuron.2006.01.020", "article-title": "M1 receptors play a central role in modulating AD-like pathology in transgenic mice", "volume": "49", "author": "Caccamo", "year": "2006", "journal-title": "Neuron"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB102|cit102", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1016/j.pharmthera.2007.09.009", "article-title": "Muscarinic acetylcholine receptors as CNS drug targets", "volume": "117", "author": "Langmead", "year": "2008", "journal-title": "Pharmacol Ther"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB103|cit103", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/j.brainresrev.2004.07.018", "article-title": "Signal transduction during amyloid-beta-peptide neurotoxicity: Role in Alzheimer disease", "volume": "47", "author": "Fuentealba", "year": "2004", "journal-title": "Brain Res Brain Res Rev"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB104|cit104", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1177/153331750502000103", "article-title": "Am integrated treatment approach improves cognitive function in demented and clinically depressed patients", "volume": "20", "author": "Bragin", "year": "2005", "journal-title": "J Alzheimers Dis Other Demen"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB105|cit105", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1017/S1041610209990184", "article-title": "Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors", "volume": "22", "author": "Rozzini", "year": "2010", "journal-title": "Int Psychogeriatr"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB106|cit106", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1212/WNL.59.3.392", "article-title": "Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation", "volume": "13", "author": "Di Lazzaro", "year": "2002", "journal-title": "Neurology"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB107|cit107", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1136/jnnp.2003.018127", "article-title": "Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease", "volume": "75", "author": "Di Lazzaro", "year": "2004", "journal-title": "J Neurol Neurosurg Psych"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB108|cit108", "doi-asserted-by": "crossref", "first-page": "2410", "DOI": "10.1016/j.clinph.2004.04.022", "article-title": "Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia", "volume": "115", "author": "Pierantozzi", "year": "2004", "journal-title": "Clin Neurophysiol"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1111/j.1471-4159.2006.03935.x", "article-title": "Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease", "volume": "98", "author": "Kirvell", "year": "2006", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB110|cit110", "doi-asserted-by": "crossref", "first-page": "1619", "DOI": "10.1016/j.neurobiolaging.2007.04.010", "article-title": "Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease", "volume": "29", "author": "Kashani", "year": "2008", "journal-title": "Neurobiol Aging"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB111|cit111", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.2174/138945007780618472", "article-title": "Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation", "volume": "8", "author": "Lipton", "year": "2007", "journal-title": "Curr Drug Targets"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB112|cit112", "doi-asserted-by": "crossref", "first-page": "4258", "DOI": "10.1096/fj.08-107268", "article-title": "Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors", "volume": "22", "author": "L\u00e9veill\u00e9", "year": "2008", "journal-title": "FASEB J"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB113|cit113", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1038/nrn2153", "article-title": "NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders", "volume": "8", "author": "Lau", "year": "2007", "journal-title": "Nat Rev Neurosci"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1016/j.neuron.2007.01.025", "article-title": "Decoding NMDA receptor signaling: Identification of genomic programs specifying neuronal survival and death", "volume": "53", "author": "Zhang", "year": "2007", "journal-title": "Neuron"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.2147/NDT.S4048", "article-title": "Update on the use of memantine in Alzheimer's disease", "volume": "5", "author": "Van Marum", "year": "2009", "journal-title": "Neuropsychiatr Dis Treat"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1016/j.brainresbull.2004.11.002", "article-title": "Indicators of neuroprotection with galantamine", "volume": "64", "author": "Geerts", "year": "2005", "journal-title": "Brain Res Bull"}, {"key": "10.1111/j.1755-5949.2010.00175.x-BIB117|cit117", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1186/1745-6215-10-57", "article-title": "DOMINO-AD team. DOMINO-AD protocol: Donepezil and memantine in moderate to severe Alzheimer's disease - A multicentre RCT", "volume": "10", "author": "Jones", "year": "2009", "journal-title": "Trials"}], "container-title": ["CNS Neuroscience & Therapeutics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-5949.2010.00175.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 1]], "date-time": "2019-03-01T10:15:18Z", "timestamp": 1551435318000}, "score": 63.452236, "subtitle": ["Beyond the Cholinergic Hypothesis"], "issued": {"date-parts": [[2010, 6, 18]]}, "references-count": 117, "URL": "http://dx.doi.org/10.1111/j.1755-5949.2010.00175.x", "relation": {"cites": []}, "ISSN": ["1755-5930", "1755-5949"], "issn-type": [{"value": "1755-5930", "type": "print"}, {"value": "1755-5949", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:01:31Z", "timestamp": 1574319691983}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CAR"], "published-print": {"date-parts": [[2007, 9, 1]]}, "DOI": "10.2174/156720507781788774", "type": "journal-article", "created": {"date-parts": [[2007, 9, 5]], "date-time": "2007-09-05T23:56:39Z", "timestamp": 1189036599000}, "page": "351-358", "source": "Crossref", "is-referenced-by-count": 41, "title": ["NGF-Cholinergic Dependency in Brain Aging, MCI and Alzheimers Disease"], "prefix": "10.2174", "volume": "4", "author": [{"given": "A.", "family": "Cuello", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Bruno", "sequence": "additional", "affiliation": []}, {"given": "K.F.", "family": "Bell", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Alzheimer Research"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/78798", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T08:50:45Z", "timestamp": 1448268645000}, "score": 30.452454, "issued": {"date-parts": [[2007, 9, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 9, 1]]}, "issue": "4"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/156720507781788774", "ISSN": ["1567-2050"], "issn-type": [{"value": "1567-2050", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:00:00Z", "timestamp": 1574240400202}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1995]]}, "DOI": "10.1097/00002093-199501002-00007", "type": "journal-article", "created": {"date-parts": [[2006, 10, 30]], "date-time": "2006-10-30T11:50:39Z", "timestamp": 1162209039000}, "page": "37", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Clinical Heterogeneity"], "prefix": "10.1097", "volume": "9", "author": [{"given": "Sarah A.", "family": "Eagger", "sequence": "first", "affiliation": []}, {"given": "Richard J.", "family": "Harvey", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T16:37:02Z", "timestamp": 1518107822000}, "score": 29.367466, "subtitle": ["Responders to Cholinergic Therapy"], "issued": {"date-parts": [[1995]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/00002093-199501002-00007", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:47:45Z", "timestamp": 1574477265154}, "publisher-location": "Boston, MA", "reference-count": 16, "publisher": "Birkh\u00e4user Boston", "isbn-type": [{"value": "9781461581512", "type": "print"}, {"value": "9781461581499", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1994]]}, "DOI": "10.1007/978-1-4615-8149-9_45", "type": "book-chapter", "created": {"date-parts": [[2012, 5, 21]], "date-time": "2012-05-21T07:54:19Z", "timestamp": 1337586859000}, "page": "265-269", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Nootropic Drugs in Alzheimer Disease Treatment. New Pharmacological Strategies"], "prefix": "10.1007", "author": [{"given": "Tatiana A.", "family": "Voronina", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "45_CR1", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1016/0163-7258(91)90035-K", "volume": "52", "author": "JA Court", "year": "1991", "unstructured": "Court JA and Perry EK (1991): Dementia \u2014 The neurochemical basis of putative transmitter orientated therapy. Pharmac Ther 52: 423\u2013443.", "journal-title": "Pharmac Ther"}, {"issue": "5", "key": "45_CR2", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1111/j.1532-5415.1976.tb06780.x", "volume": "24", "author": "D Harman", "year": "1976", "unstructured": "Harman D, Eddy DE and Noffsinger J (1976): Free radical theory of aging: inhibition of amyloidosis in mice by antioxidants; possible mechanisms. J Am Geriatr Soc 24 (5): 203\u2013210.", "journal-title": "J Am Geriatr Soc"}, {"key": "45_CR3", "first-page": "259", "volume": "3", "author": "LD Lukianova", "year": "1993", "unstructured": "Lukianova LD, Atabaeva RE and Shepeleva SG (1993): Study of bioenergetic mechanisms of antihypoxic effect of succinate containing derivative of 3hydroxypyridine (Mexidol). Bull Exper Biol Med (Moscow) 3: 259\u2013260.", "journal-title": "Study of bioenergetic mechanisms of antihypoxic effect of succinate containing derivative of 3hydroxypyridine (Mexidol). Bull Exper Biol Med (Moscow)"}, {"issue": "3", "key": "45_CR4", "first-page": "217", "volume": "12", "author": "SW Miller", "year": "1992", "unstructured": "Miller SW, Mahoney JM and Jann MW (1992): Therapeutic frontiers in Alzheimer\u2019s disease. Pharmacotherapy 12 (3): 217\u2013231.", "journal-title": "Pharmacotherapy"}, {"key": "45_CR5", "author": "R Nitsch", "first-page": "110", "year": "1991", "unstructured": "Nitsch R, Puttas A, Bluszain JK, Slak BE, Growdon JH, and Wurtman RJ (1991): Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer\u2019s disease. In: Aging and Alzheimer\u2019s Disease - Annals of New York Academy of Sciences. Growdon JH, Corkin S, Ritter-Walker J and Wurtman RI, eds. New York: Elsevier 640: 110\u2013113.", "volume-title": "Aging and Alzheimers Disease - Annals of New York Academy of Sciences"}, {"key": "45_CR6", "author": "LK Obukhova", "first-page": "150", "year": "1985", "unstructured": "Obukhova LK (1985): Molecular mechanisms inhibition of the aging by synthetical antioxidants. In: Physical chemistry and biology base of function living system. Nauka Gen Biol (Moscow) 2: 150\u2013154.", "volume-title": "Physical chemistry and biology base of function living system. Nauka Gen Biol (Moscow)"}, {"key": "45_CR7", "first-page": "28", "volume": "4", "author": "LD Smirnov", "year": "1982", "unstructured": "Smirnov LD and Dyumayev KM (1982): (3-hydroxy derivatives of six-ring nitrogen heterocycles. Synthesis, inhibitory activity and biological properties. Chem Farm J (Moscow) 4:28\u201344.", "journal-title": "Chem Farm J"}, {"issue": "1", "key": "45_CR8", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.2165/00002512-199101010-00004", "volume": "1", "author": "MW Vernon", "year": "1991", "unstructured": "Vernon MW and Sorkin EM (1991): Piracetam overview of its pharmacological properties and review of its therapeutic use in senile cognitive disorders. Drug and Aging 1 (1): 17\u201335.", "journal-title": "Drug and Aging"}, {"key": "45_CR9", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1002/ddr.430140329", "volume": "14", "author": "TA Voronina", "year": "1988", "unstructured": "Voronina TA and Kutepova OA (1988): Experimentally established gerontopsychotropic properties of 3-hydroxypyridine antioxidant. Drug Dev Res 14: 353\u2013358.", "journal-title": "Drug Dev Res"}, {"issue": "3", "key": "45_CR10", "first-page": "461", "volume": "24", "author": "TA Voronina", "year": "1988", "unstructured": "Voronina TA and Seredenin SB (1988): Analysis of the mechanism of psychotropic action of 3-hydroxypyridine derivative. Ann 1st Super Sanita 24 (3): 461\u2013466.", "journal-title": "Ann 1st Super Sanita"}, {"issue": "7", "key": "45_CR11", "first-page": "431", "volume": "10", "author": "TA Voronina", "year": "1988", "unstructured": "Voronina TA, Nerobkova LN, Garibova TL, Dikova M and Nikolov R (1988a): Effect of Nicergoline on learning and memory. Meth and Find Exptl Clin Pharmacol 10 (7): 431\u2013435.", "journal-title": "Meth and Find Exptl Clin Pharmacol"}, {"key": "45_CR12", "author": "TA Voronina", "year": "1986", "unstructured": "Voronina TA, Smirnov LD, Stolijrova LG and Garibova TL (1986): N-nicotinoyl amino acids with antihypoxic and antiamnestic activity. Patent of USSR Nr. 1368314.", "volume-title": "Patent of USSR"}, {"issue": "6", "key": "45_CR13", "doi-asserted-by": "publisher", "first-page": "2369", "DOI": "10.1016/0014-2999(90)93932-G", "volume": "183", "author": "TA Voronina", "year": "1990", "unstructured": "Voronina TA, Kutepova OA and Zolotov NN (1990a): Age-dependent impairments of learning and memory and their pharmacological correction. Europ J Pharmacol 183 (6): 2369.", "journal-title": "Europ J Pharmacol"}, {"issue": "1", "key": "45_CR14", "first-page": "55", "volume": "26", "author": "TA Voronina", "year": "1990", "unstructured": "Voronina TA, Nerobkova LN, Kutepova OA and Gugutcidse DA (1990b): Pharmacological correction of CNS functional disorders and parkinsonian syndrome in old animals. Ann lnst Super Sanita 26 (1): 55\u201360.", "journal-title": "Ann lnst Super Sanita"}, {"key": "45_CR15", "author": "TA Voronina", "first-page": "51", "year": "1992", "unstructured": "Voronina TA (1992): Present-day problems in experimental psychopharmacology of nootropic drugs. In: Soy Med Rev J Neuropharmacology, Valdman AB, ed. Harwood Academic Publisher GmbH. 2: 51\u2013106.", "volume-title": "Soy Med Rev J Neuropharmacology, Harwood Academic Publisher GmbH"}, {"key": "45_CR16", "author": "NN Zolotov", "first-page": "193", "year": "1989", "unstructured": "Zolotov NN, Voronina TA and Smirnov LD (1989): Psychotropic activity of synthetic antioxidants on the basis of 3-hydroxypyridine. A possible relationship with regulatory protease system. Regulation of the free radical reactions. Varna, Abstr. 193.", "volume-title": "Regulation of the free radical reaction"}], "container-title": ["Alzheimer Disease"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4615-8149-9_45", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T14:34:02Z", "timestamp": 1556807642000}, "score": 29.223972, "issued": {"date-parts": [[1994]]}, "ISBN": ["9781461581512", "9781461581499"], "references-count": 16, "URL": "http://dx.doi.org/10.1007/978-1-4615-8149-9_45", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:41:58Z", "timestamp": 1574246518332}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1988]]}, "DOI": "10.1097/00002093-198802030-00061", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T02:30:00Z", "timestamp": 1164162600000}, "page": "212", "source": "Crossref", "is-referenced-by-count": 4, "title": ["MULTIPLE ACTIONS OF THA ON CHOLINERGIC NEUROTRANSMISSION IN ALZHEIMER BRAINS"], "prefix": "10.1097", "volume": "2", "author": [{"given": "A.", "family": "NORDBERG", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "NILSSON", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "ADEN", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "WINBLAD", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "link": [{"URL": "http://journals.lww.com/alzheimerjournal/Fulltext/10.1097/00002093-198802030-00061", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:02:28Z", "timestamp": 1543496548000}, "score": 28.451202, "subtitle": [""], "issued": {"date-parts": [[1988]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00002093-198802030-00061", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:41:54Z", "timestamp": 1574246514344}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1988]]}, "DOI": "10.1097/00002093-198802030-00025", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T02:30:00Z", "timestamp": 1164162600000}, "page": "176", "source": "Crossref", "is-referenced-by-count": 0, "title": ["SERUM ANTIBODIES TO CHOLINERGIC NEURONS IN ALZHEIMER??S DISEASE"], "prefix": "10.1097", "volume": "2", "author": [{"given": "D. M.", "family": "MICHAELSON", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "CHAPMAN", "sequence": "additional", "affiliation": []}, {"given": "O.", "family": "BACHAR", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "FELDON", "sequence": "additional", "affiliation": []}, {"given": "A. D.", "family": "KORCZYN", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "WERTMAN", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "link": [{"URL": "http://journals.lww.com/alzheimerjournal/Fulltext/10.1097/00002093-198802030-00025", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:02:05Z", "timestamp": 1543496525000}, "score": 28.152449, "subtitle": [""], "issued": {"date-parts": [[1988]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00002093-198802030-00025", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:06:23Z", "timestamp": 1574237183198}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1987]]}, "DOI": "10.1097/00002093-198701030-00037", "type": "journal-article", "created": {"date-parts": [[2006, 10, 16]], "date-time": "2006-10-16T23:32:00Z", "timestamp": 1161041520000}, "page": "208-209", "source": "Crossref", "is-referenced-by-count": 0, "title": ["An integrative hypothesis concerning the pathogenesis and progression of Alzheimer??s disease"], "prefix": "10.1097", "volume": "1", "author": [{"given": "J A", "family": "HARDY", "sequence": "first", "affiliation": []}, {"given": "D M A", "family": "MANN", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "WESTER", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "WINBLAD", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T10:48:02Z", "timestamp": 1518173282000}, "score": 28.000053, "subtitle": [""], "issued": {"date-parts": [[1987]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00002093-198701030-00037", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T15:04:13Z", "timestamp": 1574435053934}, "publisher-location": "Berlin, Heidelberg", "reference-count": 19, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642740367", "type": "print"}, {"value": "9783642740343", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1990]]}, "DOI": "10.1007/978-3-642-74034-3_66", "type": "book-chapter", "created": {"date-parts": [[2011, 12, 19]], "date-time": "2011-12-19T20:47:51Z", "timestamp": 1324327671000}, "page": "675-683", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Modulation of Cholinergic Activity in Alzheimer Brains by Potential Drugs"], "prefix": "10.1007", "author": [{"given": "A.", "family": "Nordberg", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "Nilsson-H\u00e5kansson", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "66_CR1", "doi-asserted-by": "publisher", "first-page": "527", "DOI": "10.1126/science.3037705", "volume": "237", "author": "TI Bonner", "year": "1987", "unstructured": "Bonner TI, Buckley NJ, Young A, Brann MR (1987) Identification of a family of muscarinic receptor genes. Science 237: 527\u2013532", "journal-title": "Science"}, {"key": "66_CR2", "doi-asserted-by": "publisher", "first-page": "1333", "DOI": "10.1111/j.1471-4159.1988.tb03013.x", "volume": "50", "author": "PR Dodd", "year": "1988", "unstructured": "Dodd PR, Hambley JW, Cowburn RF, Hardy JA (1988) A comparison of methodologies for the study of functional transmitter neurochemistry in human brain. J Neurochem 50: 1333\u20131345", "journal-title": "J Neurochem"}, {"key": "66_CR3", "author": "E Giacobini", "year": "1988", "unstructured": "Giacobini E, Becker R (1988) Current research in Alzheimer therapy. Taylor and Francis, New York", "volume-title": "Current research in Alzheimer therapy"}, {"key": "66_CR4", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1007/BF00432208", "volume": "86", "author": "CG Gottfries", "year": "1985", "unstructured": "Gottfries CG (1985) Alzheimer\u2019s disease and senile dementia biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245\u2013252", "journal-title": "Psychopharmacology"}, {"key": "66_CR5", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1016/0197-0186(83)90027-X", "volume": "5", "author": "JA Hardy", "year": "1983", "unstructured": "Hardy JA, Dodd PR (1983) Metabolic and functional studies on post-mortem human brain. Neurochem Int 5: 253\u2013266", "journal-title": "Neurochem Int"}, {"key": "66_CR6", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1016/0197-0186(85)90050-6", "volume": "7", "author": "JA Hardy", "year": "1985", "unstructured": "Hardy JA, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985) Transmitter deficits in Alzheimer\u2019s disease. Neurochem Int 7: 545\u2013563", "journal-title": "Neurochem Int"}, {"key": "66_CR7", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/0014-2999(81)90147-3", "volume": "73", "author": "M Marchi", "year": "1981", "unstructured": "Marchi M, Paudice P, Raiteri M (1981) Autoregulation of acetylcholine release in isolated hippocampal nerve endings. Eur J Pharmacol 73: 75\u201379", "journal-title": "Eur J Pharmacol"}, {"key": "66_CR8", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1007/BF01243353", "volume": "67", "author": "L Nilsson", "year": "1986", "unstructured": "Nilsson L, Nordberg A, Hardy J, Wester P, Winblad B (1986) Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level. J Neural Transm 67: 275\u2013285", "journal-title": "J Neural Transm"}, {"key": "66_CR9", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1007/BF01253610", "volume": "70", "author": "L Nilsson", "year": "1987", "unstructured": "Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A (1987) Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine in AD/SDAT brains via nicotinic receptors? J Neural Transm 70: 357\u2013368", "journal-title": "J Neural Transm"}, {"key": "66_CR10", "author": "A Nordberg", "first-page": "95", "year": "1986", "unstructured": "Nordberg A, Winblad B (1986a) Brain nicotinic and muscarinic receptors in normal aging and dementia. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer\u2019s and Parkinson\u2019s disease: strategies for research and development, Plenum, New York, p 95. (Advances in behavioral biology, vol 29 )", "volume-title": "Alzheimers and Parkinsons disease: strategies for research and development", "DOI": "10.1007/978-1-4613-2179-8_12", "doi-asserted-by": "publisher"}, {"key": "66_CR11", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/0304-3940(86)90629-4", "volume": "72", "author": "A Nordberg", "year": "1986", "unstructured": "Nordberg A, Winblad B (1986b) Reduced number of 3H-nicotine and 3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72: 115\u2013119", "journal-title": "Neurosci Lett"}, {"key": "66_CR12", "author": "A Nordberg", "first-page": "231", "year": "1982", "unstructured": "Nordberg A, Adolfsson R, MarcussonJ, Winblad B (1982) Cholinergic receptors in the hippocampus in normal aging and dementia of Alzheimer type. In: Giacobini E, Vernadakis A (eds) The aging brain: cellular and molecular mechanisms of aging in the neurons system, Raven, New York, p 231 (Aging, vol 20 )", "volume-title": "The aging brain: cellular and molecular mechanisms of aging in the neurons system"}, {"key": "66_CR13", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1016/0304-3940(86)90456-8", "volume": "70", "author": "A Nordberg", "year": "1986", "unstructured": "Nordberg A, Alafuzoff I, Winblad B (1986) Muscarinic receptor subtypes in Alzheimer\u2019s disease and mixed dementia type. Neurosci Lett 70: 160\u2013164", "journal-title": "Neurosci Lett"}, {"key": "66_CR14", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1007/BF01244094", "volume": "69", "author": "A Nordberg", "year": "1987", "unstructured": "Nordberg A, Nyberg P, Adolfsson R, Winblad B (1987) Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile. J Neural Transm 69: 19\u201332", "journal-title": "J Neural Transm"}, {"key": "66_CR15", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1016/0304-3940(88)90503-4", "volume": "86", "author": "A Nordberg", "year": "1988a", "unstructured": "Nordberg A, Adem A, Hardy J, Winblad B (1988 a) Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci Lett 86: 317\u2013321", "journal-title": "Neurosci Lett"}, {"key": "66_CR16", "author": "A Nordberg", "first-page": "247", "year": "1988b", "unstructured": "Nordberg A, Nilsson L, Adem A, Hardy J, Winblad B ( 1988 b) Effect of THA on acetylcholine release and cholinergic receptors in Alzheimer brains. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy. Taylor and Francis, New York, p 247", "volume-title": "Current research in Alzheimer therapy"}, {"key": "66_CR17", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1093/oxfordjournals.bmb.a072100", "volume": "42", "author": "E Perry", "year": "1986", "unstructured": "Perry E (1986) The cholinergic hypothesis: ten years on. Br Med Bull 42: 63\u201369", "journal-title": "Br Med Bull"}, {"key": "66_CR18", "first-page": "121", "volume": "241", "author": "JC Szerb", "year": "1973", "unstructured": "Szerb JC, Somogyi GT (1973) Depression of acetylcholine release from cortical slices by cholinesterase inhibition and by oxotremorine. Nature 241: 121\u2013122", "journal-title": "Nature"}, {"key": "66_CR19", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1007/BF02834269", "volume": "3", "author": "P Wester", "year": "1985", "unstructured": "Wester P, Bateman DE, Dodd PR, Edwardson JA, Hardy JA, Kidd AM, Perry RH, Singh GB (1985) Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochem Pathol 3: 169\u2013180", "journal-title": "Neurochem Pathol"}], "container-title": ["Neuropsychopharmacology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-74034-3_66", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T04:28:28Z", "timestamp": 1572928108000}, "score": 26.768288, "issued": {"date-parts": [[1990]]}, "ISBN": ["9783642740367", "9783642740343"], "references-count": 19, "URL": "http://dx.doi.org/10.1007/978-3-642-74034-3_66", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:50:38Z", "timestamp": 1574146238064}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1986, 10, 1]], "date-time": "1986-10-01T00:00:00Z", "timestamp": 528508800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[1986, 10]]}, "DOI": "10.1016/0028-3908(86)90165-6", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T18:52:00Z", "timestamp": 1039891920000}, "page": "1161-1166", "source": "Crossref", "is-referenced-by-count": 5, "title": ["The effects of cholinergic drugs support an avoidance learning hypothesis of brief footshock-induced analgesia"], "prefix": "10.1016", "volume": "25", "author": [{"given": "A", "family": "Gower", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0028-3908(86)90165-6?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0028-3908(86)90165-6?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T02:24:22Z", "timestamp": 1554085462000}, "score": 26.4181, "issued": {"date-parts": [[1986, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1986, 10]]}, "issue": "10"}, "alternative-id": ["0028-3908(86)90165-6"], "URL": "http://dx.doi.org/10.1016/0028-3908(86)90165-6", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:22:54Z", "timestamp": 1574284974786}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1990]]}, "DOI": "10.1097/00002093-199040200-00005", "type": "journal-article", "created": {"date-parts": [[2007, 3, 29]], "date-time": "2007-03-29T08:13:58Z", "timestamp": 1175156038000}, "page": "110", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Survival of adult basal forebrain cholinergic neurons after loss of target neurons"], "prefix": "10.1097", "volume": "4", "author": [{"given": "M A", "family": "Sofroniew", "sequence": "first", "affiliation": []}, {"given": "N P", "family": "Galletly", "sequence": "additional", "affiliation": []}, {"given": "O", "family": "Isacson", "sequence": "additional", "affiliation": []}, {"given": "C N.", "family": "Svendsen", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "deposited": {"date-parts": [[2016, 12, 3]], "date-time": "2016-12-03T16:53:47Z", "timestamp": 1480784027000}, "score": 25.504137, "subtitle": [""], "issued": {"date-parts": [[1990]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1097/00002093-199040200-00005", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:41:58Z", "timestamp": 1574246518331}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1988]]}, "DOI": "10.1097/00002093-198802040-00026", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T02:30:40Z", "timestamp": 1164162640000}, "page": "396", "source": "Crossref", "is-referenced-by-count": 10, "title": ["NEUROPATHOLOGICAL DIAGNOSIS OF ALZHEIMER DISEASE"], "prefix": "10.1097", "volume": "2", "author": [{"given": "H. M.", "family": "WISNIEWSKI", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "RABE", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "SILVERMAN", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "ZIGMAN", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "link": [{"URL": "http://journals.lww.com/alzheimerjournal/Fulltext/10.1097/00002093-198802040-00026", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:03:50Z", "timestamp": 1543496630000}, "score": 25.093369, "subtitle": ["A SURVEY OF CURRENT PRACTICES"], "issued": {"date-parts": [[1988]]}, "references-count": 0, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1097/00002093-198802040-00026", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:41:58Z", "timestamp": 1574246518036}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer Disease & Associated Disorders"], "published-print": {"date-parts": [[1988]]}, "DOI": "10.1097/00002093-198802030-00065", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T02:30:00Z", "timestamp": 1164162600000}, "page": "216", "source": "Crossref", "is-referenced-by-count": 1, "title": ["CHOLINESTERASE INHIBITOR THERAPY FOR ALZHEIMER DEMENTIA"], "prefix": "10.1097", "volume": "2", "author": [{"given": "K. A.", "family": "SHERMAN", "sequence": "first", "affiliation": []}, {"given": "E.", "family": "MESSAMORE", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Alzheimer Disease & Associated Disorders"], "language": "en", "link": [{"URL": "http://journals.lww.com/alzheimerjournal/Fulltext/10.1097/00002093-198802030-00065", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:02:30Z", "timestamp": 1543496550000}, "score": 24.993206, "subtitle": ["WHAT DO ANIMAL MODELS TELL US?"], "issued": {"date-parts": [[1988]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00002093-198802030-00065", "ISSN": ["0893-0341"], "issn-type": [{"value": "0893-0341", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:03:16Z", "timestamp": 1575288196474}, "publisher-location": "Boston, MA", "reference-count": 12, "publisher": "Birkh\u00e4user Boston", "isbn-type": [{"value": "9781489967404", "type": "print"}, {"value": "9781489967381", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1991]]}, "DOI": "10.1007/978-1-4899-6738-1_43", "type": "book-chapter", "created": {"date-parts": [[2013, 10, 10]], "date-time": "2013-10-10T18:01:47Z", "timestamp": 1381428107000}, "page": "397-403", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pharmacological Actions of Recombinant Human Nerve Growth Factor on Lesioned Central Cholinergic Neurons: Rationale for the Treatment of Alzheimer\u2019s Disease"], "prefix": "10.1007", "author": [{"given": "Paul A.", "family": "Lapchak", "sequence": "first", "affiliation": []}, {"given": "Franz", "family": "Hefti", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "43_CR1", "doi-asserted-by": "publisher", "first-page": "1914", "DOI": "10.1111/j.1471-4159.1988.tb02497.x", "volume": "50", "author": "DM Araujo", "year": "1988", "unstructured": "Araujo DM, Lapchak PA, Robitaille Y, Gauthier S and Quirion R (1988): Differential alteration of various cholinergic markers in cortical and sub-cortical regions of the human brain in Alzheimer\u2019s disease. J Neurochem 50:1914\u20131923.", "journal-title": "J Neurochem"}, {"key": "43_CR2", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1007/BF00697388", "volume": "61", "author": "T Arendt", "year": "1983", "unstructured": "Arendt T, Bigl B and Tennstedt A (1983): Loss of neurons in the nucleus basalis of Meynert in Alzheimer\u2019s disease, paralysis agitans and Korsakoff\u2019s disease. Acta Neuropath 61:101\u2013108.", "journal-title": "Acta Neuropath"}, {"key": "43_CR3", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0306-4522(86)90002-3", "volume": "19", "author": "D Collerton", "year": "1986", "unstructured": "Collerton D (1986): Cholinergic function and intellectual decline in Alzheimer\u2019s disease. Neuroscience 19:1\u201328.", "journal-title": "Neuroscience"}, {"key": "43_CR4", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1016/0006-8993(84)91237-X", "volume": "293", "author": "F Hefti", "year": "1984", "unstructured": "Hefti F, Dravid A and Hartikka J (1984): Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 293:305\u2013311.", "journal-title": "Brain Res"}, {"key": "43_CR5", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/S0197-4580(89)80014-4", "volume": "10", "author": "F Hefti", "year": "1989", "unstructured": "Hefti F and Mash DC (1989): Localization of nerve growth factor receptors in the normal human brain and in Alzheimer\u2019s disease. Neurobiol Aging 10:75\u201387.", "journal-title": "Neurobiol Aging"}, {"key": "43_CR6", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1016/S0197-4580(89)80013-2", "volume": "10", "author": "JH Kordower", "year": "1989", "unstructured": "Kordower JH, Gash DM, Bothwell M, Hersh L and Mufson EJ (1989): Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer\u2019s patients. Neurobiol Aging 10:67\u201374.", "journal-title": "Neurobiol Aging"}, {"key": "43_CR7", "unstructured": "Lapchak PA and Hefti F (1991): Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septo-hippocampal lesions: measures of [3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity. Neuroscience (In Press).", "DOI": "10.1016/0306-4522(91)90033-K", "doi-asserted-by": "crossref"}, {"key": "43_CR8", "doi-asserted-by": "publisher", "first-page": "1457", "DOI": "10.1136/bmj.2.6150.1457", "volume": "2", "author": "E Perry", "year": "1978", "unstructured": "Perry E, Tomlinson BE, Blessed G, Bergmann K, Gibson PH and Perry RH (1978): Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Brit Med J 2:1457\u20131459.", "journal-title": "Brit Med J"}, {"key": "43_CR9", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/0197-4580(89)90032-8", "volume": "10", "author": "CH Phelps", "year": "1989", "unstructured": "Phelps CH, Gage FH, Growdon JH, Hefti F, Harbaugh R, Johnson MV, Khachaturian ZS, Mobley WC, Price DL, Raskind M, Simpkins J, Thal LJ and Woodcock R (1989): Potential use of nerve growth factor to treat Alzheimer\u2019s disease. Neurobiol Aging 10:205\u2013207.", "journal-title": "Neurobiol Aging"}, {"key": "43_CR10", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1016/0006-8993(83)90017-3", "volume": "289", "author": "RT Rylett", "year": "1983", "unstructured": "Rylett RT, Ball MJ and Colhoun EH (1983): Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer\u2019s disease. Brain Res 289:169\u2013175.", "journal-title": "Brain Res"}, {"key": "43_CR11", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1016/S0140-6736(80)90884-3", "volume": "1", "author": "NR Sims", "year": "1980", "unstructured": "Sims NR, Bowen DM, Smith CCT, Flock RHA, Davison AN, Snowden JS and Neary D (1980): Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer\u2019s disease. Lancet 1:333\u2013337.", "journal-title": "Lancet"}, {"key": "43_CR12", "doi-asserted-by": "publisher", "first-page": "1237", "DOI": "10.1126/science.7058341", "volume": "215", "author": "PJ Whitehouse", "year": "1982", "unstructured": "Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT and Delong MR (1982): Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237\u20131239.", "journal-title": "Science"}], "container-title": ["Cholinergic Basis for Alzheimer Therapy"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4899-6738-1_43", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 17]], "date-time": "2019-05-17T20:00:42Z", "timestamp": 1558123242000}, "score": 24.930582, "issued": {"date-parts": [[1991]]}, "ISBN": ["9781489967404", "9781489967381"], "references-count": 12, "URL": "http://dx.doi.org/10.1007/978-1-4899-6738-1_43", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:50:54Z", "timestamp": 1574812254095}, "reference-count": 93, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 6, 27]], "date-time": "2016-06-27T00:00:00Z", "timestamp": 1466985600000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100000041", "name": "American Diabetes Association", "doi-asserted-by": "publisher", "award": ["7-11-CD-06"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["CNS Drugs"], "published-print": {"date-parts": [[2016, 8]]}, "DOI": "10.1007/s40263-016-0364-1", "type": "journal-article", "created": {"date-parts": [[2016, 6, 27]], "date-time": "2016-06-27T09:59:47Z", "timestamp": 1467021587000}, "page": "667-675", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 10, "title": ["A\u03b2-Degrading Proteases: Therapeutic Potential in Alzheimer Disease"], "prefix": "10.1007", "volume": "30", "author": [{"given": "Malcolm A.", "family": "Leissring", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 6, 27]]}, "reference": [{"issue": "7266", "key": "364_CR1", "doi-asserted-by": "crossref", "first-page": "895", "DOI": "10.1038/461895a", "volume": "461", "author": "L Mucke", "year": "2009", "unstructured": "Mucke L. Neuroscience: Alzheimer\u2019s disease. Nature. 2009;461(7266):895\u20137.", "journal-title": "Nature"}, {"key": "364_CR2", "author": "M Prince", "year": "2015", "unstructured": "Prince M, Wimo A, Guerchet M, Ali GC, Wu TT, Prina M, et al. World Alzheimer\u2019s Report 2015. The global impact of dementia: an analysis of prevalence, incedence, cost and trends. London: Alzheimer\u2019s Disease International; 2015.", "volume-title": "World Alzheimer\u2019s Report 2015. The global impact of dementia: an analysis of prevalence, incedence, cost and trends"}, {"issue": "3", "key": "364_CR3", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1016/j.jalz.2015.02.003", "volume": "11", "author": "A Alzheimer\u2019s", "year": "2015", "unstructured": "Alzheimer\u2019s A. 2015 Alzheimer\u2019s disease facts and figures. Alzheimer Dement. 2015;11(3):332\u201384.", "journal-title": "Alzheimer Dement."}, {"issue": "12", "key": "364_CR4", "doi-asserted-by": "publisher", "first-page": "1045", "DOI": "10.1212/WNL.0000000000000240", "volume": "82", "author": "BD James", "year": "2014", "unstructured": "James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014;82(12):1045\u201350. doi: 10.1212/WNL.0000000000000240 .", "journal-title": "Neurology."}, {"issue": "1", "key": "364_CR5", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/j.pharep.2015.07.006", "volume": "68", "author": "J Godyn", "year": "2016", "unstructured": "Godyn J, Jonczyk J, Panek D, Malawska B. Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep. 2016;68(1):127\u201338. doi: 10.1016/j.pharep.2015.07.006 .", "journal-title": "Pharmacol Rep."}, {"issue": "5580", "key": "364_CR6", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1126/science.1072994", "volume": "297", "author": "J Hardy", "year": "2002", "unstructured": "Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136. doi: 10.1126/science.1072994 .", "journal-title": "Science"}, {"key": "364_CR7", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1146/annurev.pharmtox.43.100901.140248", "volume": "43", "author": "DJ Selkoe", "year": "2003", "unstructured": "Selkoe DJ, Schenk D. Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2003;43:545\u201384.", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "364_CR8", "author": "RE Tanzi", "year": "2012", "unstructured": "Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harbor Perspect Med. 2012. doi: 10.1101/cshperspect.a006296 .", "journal-title": "Cold Spring Harbor Perspect Med.", "DOI": "10.1101/cshperspect.a006296", "doi-asserted-by": "publisher"}, {"issue": "6", "key": "364_CR9", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1002/ana.10208", "volume": "51", "author": "RM Holsinger", "year": "2002", "unstructured": "Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer\u2019s disease. Ann Neurol. 2002;51(6):783\u20136. doi: 10.1002/ana.10208 .", "journal-title": "Ann Neurol."}, {"issue": "4", "key": "364_CR10", "doi-asserted-by": "publisher", "first-page": "710", "DOI": "10.1212/01.wnl.0000229925.52203.4c", "volume": "67", "author": "RM Holsinger", "year": "2006", "unstructured": "Holsinger RM, Lee JS, Boyd A, Masters CL, Collins SJ. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias. Neurology. 2006;67(4):710\u20132. doi: 10.1212/01.wnl.0000229925.52203.4c .", "journal-title": "Neurology."}, {"issue": "5", "key": "364_CR11", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.2174/156720506779025206", "volume": "3", "author": "MA Leissring", "year": "2006", "unstructured": "Leissring MA. Proteolytic degradation of the amyloid beta-protein: the forgotten side of Alzheimer\u2019s disease. Curr Alzheimer Res. 2006;3(5):431\u20135.", "journal-title": "Curr Alzheimer Res"}, {"issue": "5", "key": "364_CR12", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1038/nrn2620", "volume": "10", "author": "G Bu", "year": "2009", "unstructured": "Bu G. Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10(5):333\u201344. doi: 10.1038/nrn2620 .", "journal-title": "Nat Rev Neurosci"}, {"issue": "1", "key": "364_CR13", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1016/j.ab.2013.04.031", "volume": "440", "author": "KG Mawuenyega", "year": "2013", "unstructured": "Mawuenyega KG, Kasten T, Sigurdson W, Bateman RJ. Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics. Anal Biochem. 2013;440(1):56\u201362. doi: 10.1016/j.ab.2013.04.031 .", "journal-title": "Anal Biochem"}, {"issue": "6012", "key": "364_CR14", "doi-asserted-by": "publisher", "first-page": "1774", "DOI": "10.1126/science.1197623", "volume": "330", "author": "KG Mawuenyega", "year": "2010", "unstructured": "Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330(6012):1774. doi: 10.1126/science.1197623 .", "journal-title": "Science"}, {"issue": "2", "key": "364_CR15", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1038/nrneurol.2009.218", "volume": "6", "author": "B Strooper De", "year": "2010", "unstructured": "De Strooper B, Vassar R, Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol. 2010;6(2):99\u2013107.", "journal-title": "Nat Rev Neurol."}, {"issue": "2", "key": "364_CR16", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/j.cell.2007.10.012", "volume": "131", "author": "DJ Selkoe", "year": "2007", "unstructured": "Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell. 2007;131(2):215\u201321.", "journal-title": "Cell"}, {"issue": "2", "key": "364_CR17", "doi-asserted-by": "publisher", "first-page": "159", "DOI": "10.1093/hmg/ddh019", "volume": "13", "author": "JL Jankowsky", "year": "2004", "unstructured": "Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13(2):159\u201370. doi: 10.1093/hmg/ddh019 .", "journal-title": "Hum Mol Genet"}, {"issue": "5163", "key": "364_CR18", "doi-asserted-by": "crossref", "first-page": "1336", "DOI": "10.1126/science.8191290", "volume": "264", "author": "N Suzuki", "year": "1994", "unstructured": "Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 1994;264(5163):1336\u201340.", "journal-title": "Science"}, {"issue": "1", "key": "364_CR19", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/S0969-9961(03)00104-9", "volume": "14", "author": "Y Luo", "year": "2003", "unstructured": "Luo Y, Bolon B, Damore MA, Fitzpatrick D, Liu H, Zhang J, et al. BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time. Neurobiol Dis. 2003;14(1):81\u20138 (S0969996103001049 [pii]).", "journal-title": "Neurobiol Dis"}, {"issue": "3", "key": "364_CR20", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1038/85059", "volume": "4", "author": "Y Luo", "year": "2001", "unstructured": "Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, et al. Mice deficient in BACE1, the Alzheimer\u2019s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci. 2001;4(3):231\u20132. doi: 10.1038/85059 .", "journal-title": "Nat Neurosci"}, {"issue": "2", "key": "364_CR21", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.2174/156720508783954758", "volume": "5", "author": "SL Cole", "year": "2008", "unstructured": "Cole SL, Vassar R. BACE1 structure and function in health and Alzheimer\u2019s disease. Curr Alzheimer Res. 2008;5(2):100\u201320.", "journal-title": "Curr Alzheimer Res"}, {"issue": "14", "key": "364_CR22", "doi-asserted-by": "publisher", "first-page": "3157", "DOI": "10.1038/emboj.2012.173", "volume": "31", "author": "PH Kuhn", "year": "2012", "unstructured": "Kuhn PH, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M, et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J. 2012;31(14):3157\u201368. doi: 10.1038/emboj.2012.173 .", "journal-title": "EMBO J"}, {"issue": "18", "key": "364_CR23", "doi-asserted-by": "publisher", "first-page": "7856", "DOI": "10.1523/JNEUROSCI.3372-12.2013", "volume": "33", "author": "D Fleck", "year": "2013", "unstructured": "Fleck D, van Bebber F, Colombo A, Galante C, Schwenk BM, Rabe L, et al. Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J Neurosci. 2013;33(18):7856\u201369. doi: 10.1523/JNEUROSCI.3372-12.2013 .", "journal-title": "J Neurosci"}, {"issue": "8", "key": "364_CR24", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1016/j.biopsych.2014.10.013", "volume": "77", "author": "S Filser", "year": "2015", "unstructured": "Filser S, Ovsepian SV, Masana M, Blazquez-Llorca L, Brandt Elvang A, Volbracht C, et al. Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions. Biol Psychiatry. 2015;77(8):729\u201339. doi: 10.1016/j.biopsych.2014.10.013 .", "journal-title": "Biol Psychiatry"}, {"issue": "3", "key": "364_CR25", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1016/S1474-4422(13)70276-X", "volume": "13", "author": "R Yan", "year": "2014", "unstructured": "Yan R, Vassar R. Targeting the beta secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol. 2014;13(3):319\u201329. doi: 10.1016/S1474-4422(13)70276-X .", "journal-title": "Lancet Neurol"}, {"issue": "4", "key": "364_CR26", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1016/S0092-8674(00)80244-5", "volume": "89", "author": "J Shen", "year": "1997", "unstructured": "Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 1997;89(4):629\u201339.", "journal-title": "Cell"}, {"issue": "20", "key": "364_CR27", "doi-asserted-by": "crossref", "first-page": "11039", "DOI": "10.1073/pnas.211352598", "volume": "98", "author": "DJ Selkoe", "year": "2001", "unstructured": "Selkoe DJ. Presenilin, Notch, and the genesis and treatment of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2001;98(20):11039\u201341.", "journal-title": "Proc Natl Acad Sci USA."}, {"issue": "12", "key": "364_CR28", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.2174/156802611795861004", "volume": "11", "author": "A Lleo", "year": "2011", "unstructured": "Lleo A, Saura CA. gamma-secretase substrates and their implications for drug development in Alzheimer\u2019s disease. Curr Top Med Chem. 2011;11(12):1513\u201327.", "journal-title": "Curr Top Med Chem"}, {"issue": "4", "key": "364_CR29", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1016/j.cell.2014.10.016", "volume": "159", "author": "B Strooper De", "year": "2014", "unstructured": "De Strooper B. Lessons from a failed gamma-secretase Alzheimer trial. Cell. 2014;159(4):721\u20136. doi: 10.1016/j.cell.2014.10.016 .", "journal-title": "Cell"}, {"issue": "6", "key": "364_CR30", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1097/WNF.0b013e31805b7660", "volume": "30", "author": "ER Siemers", "year": "2007", "unstructured": "Siemers ER, Dean RA, Friedrich S, Ferguson-Sells L, Gonzales C, Farlow MR, et al. Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase. Clin Neuropharmacol. 2007;30(6):317\u201325. doi: 10.1097/WNF.0b013e31805b7660 .", "journal-title": "Clin Neuropharmacol"}, {"issue": "6", "key": "364_CR31", "doi-asserted-by": "publisher", "first-page": "1195", "DOI": "10.1016/j.clinthera.2015.01.002", "volume": "37", "author": "H Ascher-Svanum", "year": "2015", "unstructured": "Ascher-Svanum H, Chen YF, Hake A, Kahle-Wrobleski K, Schuster D, Kendall D, et al. Cognitive and functional decline in patients with mild alzheimer dementia with or without comorbid diabetes. Clin Ther. 2015;37(6):1195\u2013205. doi: 10.1016/j.clinthera.2015.01.002 .", "journal-title": "Clin Ther"}, {"issue": "7568", "key": "364_CR32", "doi-asserted-by": "publisher", "first-page": "212", "DOI": "10.1038/nature14892", "volume": "525", "author": "XC Bai", "year": "2015", "unstructured": "Bai XC, Yan C, Yang G, Lu P, Ma D, Sun L, et al. An atomic structure of human gamma-secretase. Nature. 2015;525(7568):212\u20137. doi: 10.1038/nature14892 .", "journal-title": "Nature"}, {"issue": "3", "key": "364_CR33", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1016/j.nurt.2008.05.010", "volume": "5", "author": "MS Wolfe", "year": "2008", "unstructured": "Wolfe MS. Inhibition and modulation of gamma-secretase for Alzheimer\u2019s disease. Neurotherapeutics. 2008;5(3):391\u20138.", "journal-title": "Neurotherapeutics."}, {"issue": "3", "key": "364_CR34", "doi-asserted-by": "publisher", "first-page": "440", "DOI": "10.1172/JCI18162", "volume": "112", "author": "JL Eriksen", "year": "2003", "unstructured": "Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, et al. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest. 2003;112(3):440\u20139. doi: 10.1172/JCI18162 .", "journal-title": "J Clin Invest."}, {"issue": "1", "key": "364_CR35", "doi-asserted-by": "publisher", "first-page": "a006304", "DOI": "10.1101/cshperspect.a006304", "volume": "2", "author": "B Strooper De", "year": "2012", "unstructured": "De Strooper B, Iwatsubo T, Wolfe MS. Presenilins and gamma-secretase: structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(1):a006304. doi: 10.1101/cshperspect.a006304 .", "journal-title": "Cold Spring Harb Perspect Med."}, {"issue": "8", "key": "364_CR36", "doi-asserted-by": "crossref", "first-page": "916", "DOI": "10.1038/78682", "volume": "6", "author": "F Bard", "year": "2000", "unstructured": "Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6(8):916\u20139.", "journal-title": "Nat Med"}, {"issue": "15", "key": "364_CR37", "doi-asserted-by": "crossref", "first-page": "8850", "DOI": "10.1073/pnas.151261398", "volume": "98", "author": "RB DeMattos", "year": "2001", "unstructured": "DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2001;98(15):8850\u20135.", "journal-title": "Proc Natl Acad Sci USA."}, {"issue": "11", "key": "364_CR38", "doi-asserted-by": "crossref", "first-page": "1270", "DOI": "10.1038/nm783", "volume": "8", "author": "C Hock", "year": "2002", "unstructured": "Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, et al. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med. 2002;8(11):1270\u20135.", "journal-title": "Nat Med"}, {"issue": "6740", "key": "364_CR39", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1038/22124", "volume": "400", "author": "D Schenk", "year": "1999", "unstructured": "Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400(6740):173\u20137.", "journal-title": "Nature"}, {"issue": "4", "key": "364_CR40", "doi-asserted-by": "crossref", "first-page": "567", "DOI": "10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.0.CO;2-W", "volume": "48", "author": "HL Weiner", "year": "2000", "unstructured": "Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, et al. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer\u2019s disease. Ann Neurol. 2000;48(4):567\u201379.", "journal-title": "Ann Neurol."}, {"issue": "9634", "key": "364_CR41", "doi-asserted-by": "publisher", "first-page": "216", "DOI": "10.1016/S0140-6736(08)61075-2", "volume": "372", "author": "C Holmes", "year": "2008", "unstructured": "Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al. Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372(9634):216\u201323. doi: 10.1016/S0140-6736(08)61075-2 .", "journal-title": "Lancet"}, {"issue": "4", "key": "364_CR42", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1016/S0896-6273(03)00294-0", "volume": "38", "author": "C Hock", "year": "2003", "unstructured": "Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Muller-Tillmanns B, et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease. Neuron. 2003;38(4):547\u201354.", "journal-title": "Neuron"}, {"issue": "4", "key": "364_CR43", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1038/nm840", "volume": "9", "author": "JA Nicoll", "year": "2003", "unstructured": "Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med. 2003;9(4):448\u201352.", "journal-title": "Nat Med"}, {"issue": "8", "key": "364_CR44", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1038/nrneurol.2012.118", "volume": "8", "author": "YH Liu", "year": "2012", "unstructured": "Liu YH, Giunta B, Zhou HD, Tan J, Wang YJ. Immunotherapy for Alzheimer disease: the challenge of adverse effects. Nat Rev Neurol. 2012;8(8):465\u20139. doi: 10.1038/nrneurol.2012.118 .", "journal-title": "Nat Rev Neurol."}, {"key": "364_CR45", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.3389/fnins.2014.00235", "volume": "8", "author": "JP Fuller", "year": "2014", "unstructured": "Fuller JP, Stavenhagen JB, Teeling JL. New roles for Fc receptors in neurodegeneration\u2014the impact on immunotherapy for Alzheimer\u2019s disease. Front Neurosci. 2014;8:235. doi: 10.3389/fnins.2014.00235 .", "journal-title": "Front Neurosci."}, {"issue": "41", "key": "364_CR46", "doi-asserted-by": "crossref", "first-page": "30471", "DOI": "10.1074/jbc.M605827200", "volume": "281", "author": "EA Eckman", "year": "2006", "unstructured": "Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH, et al. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem. 2006;281(41):30471\u20138.", "journal-title": "J Biol Chem"}, {"issue": "27", "key": "364_CR47", "doi-asserted-by": "crossref", "first-page": "24540", "DOI": "10.1074/jbc.M007579200", "volume": "276", "author": "EA Eckman", "year": "2001", "unstructured": "Eckman EA, Reed DK, Eckman CB. Degradation of the Alzheimer\u2019s amyloid beta peptide by endothelin-converting enzyme. J Biol Chem. 2001;276(27):24540\u20138.", "journal-title": "J Biol Chem"}, {"issue": "8", "key": "364_CR48", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1038/nrneurol.2015.119", "volume": "11", "author": "JM Tarasoff-Conway", "year": "2015", "unstructured": "Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain\u2014implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370. doi: 10.1038/nrneurol.2015.119 .", "journal-title": "Nat Rev Neurol."}, {"key": "364_CR49", "author": "MA Leissring", "first-page": "387", "year": "2011", "unstructured": "Leissring MA, Saido TC. Degradation of amyloid-\u03b2 protein. In: Selkoe DJ, Mandelkow E, Holtzman DM, editors. The biology of Alzheimer disease. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2011. p. 387\u2013404.", "volume-title": "The biology of Alzheimer disease"}, {"issue": "6", "key": "364_CR50", "doi-asserted-by": "publisher", "first-page": "a006379", "DOI": "10.1101/cshperspect.a006379", "volume": "2", "author": "T Saido", "year": "2012", "unstructured": "Saido T, Leissring MA. Proteolytic degradation of amyloid \u03b2-protein. Cold Spring Harb Perspect Med. 2012;2(6):a006379. doi: 10.1101/cshperspect.a006379 .", "journal-title": "Cold Spring Harb Perspect Med."}, {"issue": "6", "key": "364_CR51", "doi-asserted-by": "publisher", "first-page": "703", "DOI": "10.1016/j.neuron.2006.07.027", "volume": "51", "author": "S Mueller-Steiner", "year": "2006", "unstructured": "Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer\u2019s disease. Neuron. 2006;51(6):703\u201314. doi: 10.1016/j.neuron.2006.07.027 .", "journal-title": "Neuron"}, {"issue": "3", "key": "364_CR52", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.2174/0929866043407174", "volume": "11", "author": "DM Walsh", "year": "2004", "unstructured": "Walsh DM, Selkoe DJ. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett. 2004;11(3):213\u201328.", "journal-title": "Protein Pept Lett"}, {"issue": "2", "key": "364_CR53", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1016/j.nbd.2009.07.021", "volume": "36", "author": "GM Shankar", "year": "2009", "unstructured": "Shankar GM, Leissring MA, Adame A, Sun X, Spooner E, Masliah E, et al. Biochemical and immunohistochemical analysis of an Alzheimer\u2019s disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiol Dis. 2009;36(2):293\u2013302.", "journal-title": "Neurobiol Dis"}, {"issue": "6", "key": "364_CR54", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1016/S0896-6273(03)00787-6", "volume": "40", "author": "MA Leissring", "year": "2003", "unstructured": "Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron. 2003;40(6):1087\u201393.", "journal-title": "Neuron"}, {"issue": "7", "key": "364_CR55", "doi-asserted-by": "publisher", "first-page": "1977", "DOI": "10.1523/JNEUROSCI.2984-08.2009", "volume": "29", "author": "WJ Meilandt", "year": "2009", "unstructured": "Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce-Levie K, et al. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci. 2009;29(7):1977\u201386. doi: 10.1523/JNEUROSCI.2984-08.2009 .", "journal-title": "J Neurosci"}, {"issue": "4", "key": "364_CR56", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1186/alzrt194", "volume": "5", "author": "MA Leissring", "year": "2013", "unstructured": "Leissring MA, Turner AJ. Regulation of distinct pools of amyloid beta-protein by multiple cellular proteases. Alzheimer Res Ther. 2013;5(4):37. doi: 10.1186/alzrt194 .", "journal-title": "Alzheimer Res Ther."}, {"issue": "7", "key": "364_CR57", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1038/nrn2168", "volume": "8", "author": "FM LaFerla", "year": "2007", "unstructured": "LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer\u2019s disease. Nat Rev Neurosci. 2007;8(7):499\u2013509.", "journal-title": "Nat Rev Neurosci"}, {"key": "364_CR58", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.3389/fnagi.2014.00229", "volume": "6", "author": "MA Leissring", "year": "2014", "unstructured": "Leissring MA. A\u03b2 degradation-the inside story. Front Aging Neurosci. 2014;6:229. doi: 10.3389/fnagi.2014.00229 .", "journal-title": "Front Aging Neurosci."}, {"issue": "1", "key": "364_CR59", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.1016/S0925-4439(01)00054-0", "volume": "1537", "author": "PA Lewis", "year": "2001", "unstructured": "Lewis PA, Piper S, Baker M, Onstead L, Murphy MP, Hardy J, et al. Expression of BRI-amyloid beta peptide fusion proteins: a novel method for specific high-level expression of amyloid beta peptides. Biochim Biophys Acta. 2001;1537(1):58\u201362.", "journal-title": "Biochim Biophys Acta"}, {"issue": "3", "key": "364_CR60", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.1523/JNEUROSCI.4849-06.2007", "volume": "27", "author": "J Kim", "year": "2007", "unstructured": "Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, et al. Abeta40 inhibits amyloid deposition in vivo. J Neurosci. 2007;27(3):627\u201333. doi: 10.1523/JNEUROSCI.4849-06.2007 .", "journal-title": "J Neurosci"}, {"key": "364_CR61", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1186/1750-1326-8-15", "volume": "8", "author": "J Kim", "year": "2013", "unstructured": "Kim J, Chakrabarty P, Hanna A, March A, Dickson DW, Borchelt DR, et al. Normal cognition in transgenic BRI2-Abeta mice. Mol Neurodegener. 2013;8:15. doi: 10.1186/1750-1326-8-15 .", "journal-title": "Mol Neurodegener."}, {"issue": "44", "key": "364_CR62", "doi-asserted-by": "crossref", "first-page": "29645", "DOI": "10.1074/jbc.R800022200", "volume": "283", "author": "MA Leissring", "year": "2008", "unstructured": "Leissring MA. The A\u03b2Cs of A\u03b2-cleaving proteases. J Biol Chem. 2008;283(44):29645\u20139.", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "364_CR63", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1523/JNEUROSCI.23-01-00029.2003", "volume": "23", "author": "Y Matsuoka", "year": "2003", "unstructured": "Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, et al. Novel therapeutic approach for the treatment of Alzheimer\u2019s disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci. 2003;23(1):29\u201333.", "journal-title": "J Neurosci"}, {"issue": "8", "key": "364_CR64", "doi-asserted-by": "publisher", "first-page": "1381", "DOI": "10.1038/mt.2009.115", "volume": "17", "author": "Y Liu", "year": "2009", "unstructured": "Liu Y, Studzinski C, Beckett T, Guan H, Hersh MA, Murphy MP, et al. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease. Mol Ther. 2009;17(8):1381\u20136. doi: 10.1038/mt.2009.115 .", "journal-title": "Mol Ther"}, {"issue": "2", "key": "364_CR65", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/j.mcn.2010.05.014", "volume": "45", "author": "Y Liu", "year": "2010", "unstructured": "Liu Y, Studzinski C, Beckett T, Murphy MP, Klein RL, Hersh LB. Circulating neprilysin clears brain amyloid. Mol Cell Neurosci. 2010;45(2):101\u20137. doi: 10.1016/j.mcn.2010.05.014 .", "journal-title": "Mol Cell Neurosci"}, {"issue": "Pt 2", "key": "364_CR66", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1093/brain/awt308", "volume": "137", "author": "SJ Henderson", "year": "2014", "unstructured": "Henderson SJ, Andersson C, Narwal R, Janson J, Goldschmidt TJ, Appelkvist P, et al. Sustained peripheral depletion of amyloid-beta with a novel form of neprilysin does not affect central levels of amyloid-beta. Brain. 2014;137(Pt 2):553\u201364. doi: 10.1093/brain/awt308 .", "journal-title": "Brain."}, {"issue": "6", "key": "364_CR67", "doi-asserted-by": "publisher", "first-page": "2457", "DOI": "10.1523/JNEUROSCI.3407-12.2013", "volume": "33", "author": "JR Walker", "year": "2013", "unstructured": "Walker JR, Pacoma R, Watson J, Ou W, Alves J, Mason DE, et al. Enhanced proteolytic clearance of plasma Abeta by peripherally administered neprilysin does not result in reduced levels of brain Abeta in mice. J Neurosci. 2013;33(6):2457\u201364. doi: 10.1523/JNEUROSCI.3407-12.2013 .", "journal-title": "J Neurosci"}, {"issue": "50", "key": "364_CR68", "doi-asserted-by": "publisher", "first-page": "49789", "DOI": "10.1074/jbc.M308983200", "volume": "278", "author": "ES Song", "year": "2003", "unstructured": "Song ES, Juliano MA, Juliano L, Hersh LB. Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development. J Biol Chem. 2003;278(50):49789\u201394. doi: 10.1074/jbc.M308983200 .", "journal-title": "J Biol Chem"}, {"issue": "6", "key": "364_CR69", "doi-asserted-by": "publisher", "first-page": "2246", "DOI": "10.1021/jm301280p", "volume": "56", "author": "SO Abdul-Hay", "year": "2013", "unstructured": "Abdul-Hay SO, Lane AL, Caulfield TR, Claussin C, Bertrand J, Masson A, et al. Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity. J Med Chem. 2013;56(6):2246\u201355. doi: 10.1021/jm301280p .", "journal-title": "J Med Chem"}, {"issue": "6", "key": "364_CR70", "doi-asserted-by": "crossref", "first-page": "1992", "DOI": "10.1523/JNEUROSCI.23-06-01992.2003", "volume": "23", "author": "RA Marr", "year": "2003", "unstructured": "Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003;23(6):1992\u20136.", "journal-title": "J Neurosci"}, {"key": "364_CR71", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1186/1471-2202-9-109", "volume": "9", "author": "B Spencer", "year": "2008", "unstructured": "Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, et al. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci. 2008;9:109. doi: 10.1186/1471-2202-9-109 .", "journal-title": "BMC Neurosci."}, {"issue": "5", "key": "364_CR72", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1038/nm1239", "volume": "11", "author": "MH Tuszynski", "year": "2005", "unstructured": "Tuszynski MH, Thal L, Pay M, Salmon DP, U H-S, Bakay R et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;11(5):551\u20135. doi: 10.1038/nm1239 .", "journal-title": "Nat Med"}, {"issue": "10", "key": "364_CR73", "doi-asserted-by": "publisher", "first-page": "1139", "DOI": "10.1001/jamaneurol.2015.1807", "volume": "72", "author": "MH Tuszynski", "year": "2015", "unstructured": "Tuszynski MH, Yang JH, Barba D, U H-S, Bakay RA, Pay MM et al. Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol. 2015;72(10):1139\u201347. doi: 10.1001/jamaneurol.2015.1807 .", "journal-title": "JAMA Neurol"}, {"issue": "9", "key": "364_CR74", "doi-asserted-by": "publisher", "first-page": "1325", "DOI": "10.1002/jnr.23564", "volume": "93", "author": "Y Li", "year": "2015", "unstructured": "Li Y, Wang J, Zhang S, Liu Z. Neprilysin gene transfer: a promising therapeutic approach for Alzheimer\u2019s disease. J Neurosci Res. 2015;93(9):1325\u20139. doi: 10.1002/jnr.23564 .", "journal-title": "J Neurosci Res"}, {"issue": "1", "key": "364_CR75", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.3233/JAD-2012-120658", "volume": "32", "author": "NU Barua", "year": "2012", "unstructured": "Barua NU, Miners JS, Bienemann AS, Wyatt MJ, Welser K, Tabor AB, et al. Convection-enhanced delivery of neprilysin: a novel amyloid-beta-degrading therapeutic strategy. J Alzheimers Dis. 2012;32(1):43\u201356. doi: 10.3233/JAD-2012-120658 .", "journal-title": "J Alzheimers Dis"}, {"key": "364_CR76", "doi-asserted-by": "publisher", "first-page": "1472", "DOI": "10.1038/srep01472", "volume": "3", "author": "N Iwata", "year": "2013", "unstructured": "Iwata N, Sekiguchi M, Hattori Y, Takahashi A, Asai M, Ji B, et al. Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice. Sci Rep. 2013;3:1472. doi: 10.1038/srep01472 .", "journal-title": "Sci Rep."}, {"issue": "1", "key": "364_CR77", "doi-asserted-by": "publisher", "first-page": "e16575", "DOI": "10.1371/journal.pone.0016575", "volume": "6", "author": "B Spencer", "year": "2011", "unstructured": "Spencer B, Marr RA, Gindi R, Potkar R, Michael S, Adame A, et al. Peripheral delivery of a CNS targeted, metalo-protease reduces a\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease. PLoS One. 2011;6(1):e16575. doi: 10.1371/journal.pone.0016575 .", "journal-title": "PLoS One"}, {"issue": "18", "key": "364_CR78", "doi-asserted-by": "publisher", "first-page": "7594", "DOI": "10.1073/pnas.0702170104", "volume": "104", "author": "BJ Spencer", "year": "2007", "unstructured": "Spencer BJ, Verma IM. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci USA. 2007;104(18):7594\u20139. doi: 10.1073/pnas.0702170104 .", "journal-title": "Proc Natl Acad Sci USA."}, {"issue": "25", "key": "364_CR79", "doi-asserted-by": "publisher", "first-page": "17917", "DOI": "10.1074/jbc.M114.557439", "volume": "289", "author": "B Spencer", "year": "2014", "unstructured": "Spencer B, Verma I, Desplats P, Morvinski D, Rockenstein E, Adame A, et al. A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis. J Biol Chem. 2014;289(25):17917\u201331. doi: 10.1074/jbc.M114.557439 .", "journal-title": "J Biol Chem"}, {"issue": "25", "key": "364_CR80", "doi-asserted-by": "crossref", "first-page": "8754", "DOI": "10.1073/pnas.0710823105", "volume": "105", "author": "JS Jacobsen", "year": "2008", "unstructured": "Jacobsen JS, Comery TA, Martone RL, Elokdah H, Crandall DL, Oganesian A, et al. Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci USA. 2008;105(25):8754\u20139.", "journal-title": "Proc Natl Acad Sci USA."}, {"key": "364_CR81", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1111/j.1749-6632.2000.tb06354.x", "volume": "903", "author": "WE Nostrand Van", "year": "2000", "unstructured": "Van Nostrand WE, Melchor J, Wagner M, Davis J. Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall. Ann N Y Acad Sci. 2000;903:89\u201396.", "journal-title": "Ann N Y Acad Sci"}, {"issue": "9", "key": "364_CR82", "doi-asserted-by": "crossref", "first-page": "3696", "DOI": "10.1210/en.2005-0377", "volume": "146", "author": "AM Efanov", "year": "2005", "unstructured": "Efanov AM, Barrett DG, Brenner MB, Briggs SL, Delaunois A, Durbin JD, et al. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology. 2005;146(9):3696\u2013701.", "journal-title": "Endocrinology"}, {"issue": "4", "key": "364_CR83", "doi-asserted-by": "crossref", "first-page": "e5274", "DOI": "10.1371/journal.pone.0005274", "volume": "4", "author": "C Cabrol", "year": "2009", "unstructured": "Cabrol C, Huzarska MA, Dinolfo C, Rodriguez MC, Reinstatler L, Ni J, et al. Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening. PLoS One. 2009;4(4):e5274.", "journal-title": "PLoS One"}, {"issue": "4", "key": "364_CR84", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1159/000057749", "volume": "127", "author": "SJ Bae", "year": "2002", "unstructured": "Bae SJ, Matsunaga Y, Takenaka M, Tanaka Y, Hamazaki Y, Shimizu K, et al. Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts. Int Arch Allergy Immunol. 2002;127(4):316\u201321.", "journal-title": "Int Arch Allergy Immunol"}, {"issue": "1\u20133", "key": "364_CR85", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/S0014-5793(04)00169-3", "volume": "562", "author": "MH Mohajeri", "year": "2004", "unstructured": "Mohajeri MH, Kuehnle K, Li H, Poirier R, Tracy J, Nitsch RM. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer\u2019s disease. FEBS Lett. 2004;562(1\u20133):16\u201321.", "journal-title": "FEBS Lett"}, {"issue": "38", "key": "364_CR86", "doi-asserted-by": "crossref", "first-page": "35460", "DOI": "10.1074/jbc.M202899200", "volume": "277", "author": "MH Mohajeri", "year": "2002", "unstructured": "Mohajeri MH, Wollmer MA, Nitsch RM. Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J Biol Chem. 2002;277(38):35460\u20135.", "journal-title": "J Biol Chem"}, {"issue": "53", "key": "364_CR87", "doi-asserted-by": "publisher", "first-page": "41443", "DOI": "10.1074/jbc.M110.141390", "volume": "285", "author": "ND Belyaev", "year": "2010", "unstructured": "Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, et al. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a \u03b2-secretase-dependent pathway. J Biol Chem. 2010;285(53):41443\u201354. doi: 10.1074/jbc.M110.141390 .", "journal-title": "J Biol Chem"}, {"issue": "4", "key": "364_CR88", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1016/j.neuron.2005.04.008", "volume": "46", "author": "R Pardossi-Piquard", "year": "2005", "unstructured": "Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, et al. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron. 2005;46(4):541\u201354.", "journal-title": "Neuron"}, {"issue": "1", "key": "364_CR89", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1016/j.neulet.2004.05.085", "volume": "367", "author": "J Huang", "year": "2004", "unstructured": "Huang J, Guan H, Booze RM, Eckman CB, Hersh LB. Estrogen regulates neprilysin activity in rat brain. Neurosci Lett. 2004;367(1):85\u20137. doi: 10.1016/j.neulet.2004.05.085 .", "journal-title": "Neurosci Lett"}, {"issue": "5", "key": "364_CR90", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1016/j.cell.2005.01.015", "volume": "120", "author": "O Lazarov", "year": "2005", "unstructured": "Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 2005;120(5):701\u201313.", "journal-title": "Cell"}, {"issue": "4", "key": "364_CR91", "doi-asserted-by": "publisher", "first-page": "434", "DOI": "10.1038/nm1206", "volume": "11", "author": "T Saito", "year": "2005", "unstructured": "Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, et al. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med. 2005;11(4):434\u20139. doi: 10.1038/nm1206 .", "journal-title": "Nat Med"}, {"issue": "6\u20137", "key": "364_CR92", "doi-asserted-by": "crossref", "first-page": "494", "DOI": "10.1078/094471103322331449", "volume": "10", "author": "MF Melzig", "year": "2003", "unstructured": "Melzig MF, Janka M. Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract. Phytomedicine. 2003;10(6\u20137):494\u20138.", "journal-title": "Phytomedicine"}, {"issue": "11", "key": "364_CR93", "doi-asserted-by": "publisher", "first-page": "e14015", "DOI": "10.1371/journal.pone.0014015", "volume": "5", "author": "A Parachikova", "year": "2010", "unstructured": "Parachikova A, Green KN, Hendrix C, LaFerla FM. Formulation of a medical food cocktail for Alzheimer\u2019s disease: beneficial effects on cognition and neuropathology in a mouse model of the disease. PLoS One. 2010;5(11):e14015. doi: 10.1371/journal.pone.0014015 .", "journal-title": "PLoS One"}], "container-title": ["CNS Drugs"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s40263-016-0364-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s40263-016-0364-1/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s40263-016-0364-1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 10]], "date-time": "2019-09-10T07:33:48Z", "timestamp": 1568100828000}, "score": 24.715899, "issued": {"date-parts": [[2016, 6, 27]]}, "references-count": 93, "journal-issue": {"published-print": {"date-parts": [[2016, 8]]}, "issue": "8"}, "alternative-id": ["364"], "URL": "http://dx.doi.org/10.1007/s40263-016-0364-1", "relation": {"cites": []}, "ISSN": ["1172-7047", "1179-1934"], "issn-type": [{"value": "1172-7047", "type": "print"}, {"value": "1179-1934", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T16:51:55Z", "timestamp": 1574355115383}, "reference-count": 112, "publisher": "Elsevier", "isbn-type": [{"value": "9780444807199", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1986]]}, "DOI": "10.1016/s0079-6123(08)60644-5", "type": "book-chapter", "created": {"date-parts": [[2008, 3, 3]], "date-time": "2008-03-03T19:29:42Z", "timestamp": 1204572582000}, "page": "91-103", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Cholinergic Dysfunction in Alzheimer Disease: Cause or Effect?"], "prefix": "10.1016", "author": [{"given": "Daniel A.", "family": "Plotkin", "sequence": "first", "affiliation": []}, {"given": "Lissy F.", "family": "Jarvik", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Progress in Brain Research"], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T15:29:12Z", "timestamp": 1557329352000}, "score": 24.63097, "issued": {"date-parts": [[1986]]}, "ISBN": ["9780444807199"], "references-count": 112, "URL": "http://dx.doi.org/10.1016/s0079-6123(08)60644-5", "ISSN": ["0079-6123"], "issn-type": [{"value": "0079-6123", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T00:50:13Z", "timestamp": 1575507013731}, "reference-count": 0, "publisher": "Clarivate Analytics (US)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs Fut"], "published-print": {"date-parts": [[2012]]}, "DOI": "10.1358/dof.2012.037.012.1910722", "type": "journal-article", "created": {"date-parts": [[2014, 7, 22]], "date-time": "2014-07-22T05:58:24Z", "timestamp": 1406008704000}, "page": "885", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Spotlight on...Alzheimer\u00b4s disease"], "prefix": "10.1358", "volume": "37", "author": [{"given": "A.", "family": "Al-Shamahi", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Jago", "sequence": "additional", "affiliation": []}], "member": "71", "container-title": ["Drugs of the Future"], "language": "en", "deposited": {"date-parts": [[2014, 7, 22]], "date-time": "2014-07-22T05:58:33Z", "timestamp": 1406008713000}, "score": 24.519934, "issued": {"date-parts": [[2012]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1358/dof.2012.037.012.1910722", "ISSN": ["0377-8282"], "issn-type": [{"value": "0377-8282", "type": "print"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:45:04Z", "timestamp": 1574405104829}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "999", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CAR"], "published-print": {"date-parts": [[2010, 1, 9]]}, "DOI": "10.2174/1567210197155532050", "type": "journal-article", "created": {"date-parts": [[2010, 1, 12]], "date-time": "2010-01-12T16:44:27Z", "timestamp": 1263314667000}, "page": "1-9", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genetic Susceptibility to Behavioural and Psychological Symptoms in Alzheimer Disease"], "prefix": "10.2174", "volume": "999", "author": [{"given": "A.", "family": "Padovani", "sequence": "first", "affiliation": []}], "member": "965", "container-title": ["Current Alzheimer Research"], "language": "en", "deposited": {"date-parts": [[2010, 1, 12]], "date-time": "2010-01-12T16:44:29Z", "timestamp": 1263314669000}, "score": 24.442144, "issued": {"date-parts": [[2010, 1, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 1, 9]]}, "issue": "999"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/1567210197155532050", "ISSN": ["1567-2050"], "issn-type": [{"value": "1567-2050", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:49:45Z", "timestamp": 1576781385712}, "reference-count": 0, "publisher": "IOS Press", "issue": "s2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAD"], "published-print": {"date-parts": [[2012, 6, 8]]}, "DOI": "10.3233/jad-2012-111376", "type": "journal-article", "created": {"date-parts": [[2018, 5, 16]], "date-time": "2018-05-16T08:48:21Z", "timestamp": 1526460501000}, "page": "S251-S268", "source": "Crossref", "is-referenced-by-count": 31, "title": ["The Renin-Angiotensin System and Antihypertensive Drugs in Alzheimer's Disease: Current Standing of the Angiotensin Hypothesis?"], "prefix": "10.3233", "volume": "30", "author": [{"given": "Patrick G.", "family": "Kehoe", "sequence": "first", "affiliation": [{"name": "Dementia Research Group, John James Laboratories, Frenchay Hospital, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol, UK"}]}, {"given": "Peter A.", "family": "Passmore", "sequence": "additional", "affiliation": [{"name": "Centre for Public Health, Institute of Clinical Sciences, The Queen's University of Belfast, Belfast, UK"}]}], "member": "7437", "container-title": ["Journal of Alzheimer's Disease"], "link": [{"URL": "https://content.iospress.com/download?id=10.3233/JAD-2012-111376", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T07:43:52Z", "timestamp": 1575359032000}, "score": 24.391926, "editor": [{"given": "Vincenza", "family": "Frisardi", "sequence": "additional", "affiliation": []}, {"given": "Bruno", "family": "Imbimbo", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2012, 6, 8]]}, "references-count": 0, "journal-issue": {"issue": "s2"}, "URL": "http://dx.doi.org/10.3233/jad-2012-111376", "ISSN": ["1875-8908", "1387-2877"], "issn-type": [{"value": "1387-2877", "type": "print"}, {"value": "1875-8908", "type": "electronic"}], "subject": ["Clinical Psychology", "Geriatrics and Gerontology", "Psychiatry and Mental health", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T10:29:48Z", "timestamp": 1575196188139}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "999", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CMC"], "published-print": {"date-parts": [[2013, 3, 1]]}, "DOI": "10.2174/09298673113209990113", "type": "journal-article", "created": {"date-parts": [[2013, 3, 7]], "date-time": "2013-03-07T03:46:28Z", "timestamp": 1362627988000}, "page": "50-57", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Multitarget Drugs of Plants Origin Acting on Alzheimer`s Disease"], "prefix": "10.2174", "volume": "999", "author": [{"given": "P.", "family": "Russo", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Frustaci", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Del Bufalo", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Fini", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Cesario", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Medicinal Chemistry"], "language": "en", "deposited": {"date-parts": [[2013, 3, 7]], "date-time": "2013-03-07T03:46:35Z", "timestamp": 1362627995000}, "score": 23.981386, "issued": {"date-parts": [[2013, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 3, 1]]}, "issue": "999"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/09298673113209990113", "ISSN": ["0929-8673"], "issn-type": [{"value": "0929-8673", "type": "print"}], "subject": ["Molecular Medicine", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T08:09:50Z", "timestamp": 1574410190014}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CAR"], "published-print": {"date-parts": [[2010, 3, 1]]}, "DOI": "10.2174/156720510790691173", "type": "journal-article", "created": {"date-parts": [[2010, 2, 9]], "date-time": "2010-02-09T22:19:23Z", "timestamp": 1265753963000}, "page": "158-164", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Genetic Susceptibility to Behavioural and Psychological Symptoms in Alzheimer Disease"], "prefix": "10.2174", "volume": "7", "author": [{"given": "B.", "family": "Borroni", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Costanzi", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Padovani", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Alzheimer Research"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/85768", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T09:12:31Z", "timestamp": 1448269951000}, "score": 23.720552, "issued": {"date-parts": [[2010, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 3, 1]]}, "issue": "2"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/156720510790691173", "ISSN": ["1567-2050"], "issn-type": [{"value": "1567-2050", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}